Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Jan 2023| HLC102D| BCC Publishing

Report Highlights

The global CGM market should reach $20.7 billion by 2022 and $32.7 billion by 2027, with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2022-2027.

Report Includes

  • 27 data tables and 28 additional tables
  • A detailed overview and an up-to-date analysis of the global markets for continuous glucose monitoring (CGM) devices and technologies
  • Analyses of the global market trends, with historic market revenue (sales figures) for 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of market opportunities for this innovation-driven continuous glucose monitoring devices market, and the major regions and countries involved in market developments
  • Estimation of the actual market size and revenue forecast for CGM devices in USD million values, and corresponding market share analysis by technology type, end-user settings, type of diabetes, user age group, and region
  • Country specific data and market value analysis for the United States, Canada, Germany, U.K., France, Italy, Japan, China, South Korea, etc.
  • Reassessment of the critical issues surrounding CGM transmitters/receivers, self-monitoring blood glucose (SMBG) equipment and test strips, and durable insulin pumps; their recent technological advancements, geographic trends, market dynamics, and adoption trends
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
  • Review of the key patent grants and patent applications within select CGM technologies
  • Company profiles of major players within the industry, including Abbott Laboratories, F. Hoffmann-La Roche, Medtronic PLC, Novo Nordisk, and Sanofi S.A.

Report Scope

The scope of this study encompasses the current and forecast markets for glucose monitoring, connected pumps and pens, SMBG meters, and test strips. The covered segments are CGM transmitters, receivers and sensors, smart pumps and pens, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all types of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM devices. The report also includes discussions of the market opportunities, patent scenario, market projections and market shares, competitive landscape, and the key company profiles. The report would also cover the COVID-19 impact on the CGM market.

Frequently Asked Questions (FAQs)

The continuous glucose monitoring (CGM) devices market is projected to grow from $20.7 billion in 2022 to $32.7 billion in 2027, at a compound annual growth rate (CAGR) of 9.5% during the forecast period.
The key factors driving the growth of the market include growing prevalence of diabetes population, growing evidence on benefits of the CGM use, and growing development of closed-loop systems.
The continuous glucose monitoring (CGM) devices market is segmented on the technology type, disease type, user’s age group, end-user settings and region.
SMBG (Self-monitoring blood glucose) will dominate the market by the end of 2027.
North America holds the highest share in the market.
Key companies in the market includes Abbott, Dexcom, Medtronic.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $18.7 billion
Market size forecast $32.7 billion
Growth rate CAGR of 9.5% for the forecast period of 2022-2027
Units considered $ Billions
Segments covered Type, Disease Type, Region, Ages, End-User Settings
Regions covered North America, Europe, Asia, Rest of World
Companies studied
  • ABBOTT
  • BETA BIONICS
  • BIGFOOT BIOMEDICAL INC.
  • DEXCOM INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • INSULET CORP.
  • LIFESCAN IP HOLDINGS LLC.
  • MEDTRONIC
  • NOVO NORDISK A/S
  • PKVITALITY
  • SANOFI
  • SENSEONICS HOLDINGS INC.
  • TANDEM DIABETES CARE INC.
  • YPSOMED AG
  • ASCENSIA DIABETES CARE HOLDINGS AG
  • EMPERRA GMBH E-HEALTH TECHNOLOGIES
  • GLUCOTRACK INC.
  • INTUITY MEDICAL INC.
  • NEMAURA MEDICAL INC.
  • NOVIOSENSE BV
  • QLIBRIUM
  • SINOCARE INC.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Continuous Glucose Monitoring (CGM): Technologies and Global Markets123Free
Chapter- 1: Introduction9Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background13Free
Chapter- 4: Market Breakdown by Technology Type10Free
Chapter- 5: Market Breakdown by End-User Settings6Free
Chapter- 6: CGM Market by Type of Diabetes8Free
Chapter- 7: CGM Markets, by User's Age 8Free
Chapter- 8: Market Breakdown by Region18Free
Chapter- 9: Patent Review4Free
Chapter- 10: Competitive Landscape2Free
Chapter- 11: COVID-19 Impact on the CGM Market3Free
Chapter- 12: Analysis of the Market Opportunities2Free
Chapter- 13: Company Profiles37Free
Published - Jan-2018| Analyst - Valerie Kellogg| Code - HLC102C

Report Highlights

The global market for continuous glucose monitoring devices and diabetes-related products totaled nearly $12.1 billion in 2016. The market should reach nearly $12.8 billion in 2017 and $20.7 billion in 2022, registering a compound annual growth (CAGR) of 10.1% from 2017-2022.

Report Includes

  • 52 data tables and 20 additional tables
  • An overview of the global market for continuous glucose monitoring (CGM)
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Examination of the critical issues within the CGM market, including technological developments, geographic trends, market dynamics, and adoption trends
  • Market breakdowns by application area: hospitals, diagnostics/clinics, home
  • Information broken down by age: children, teens, young, middle, elderly; by race: non-Hispanic whites, Hispanics, Asian-Americans, Europeans, Asians, others; and by geography: the U.S., Europe, Asia, and the rest of the world
  • Information on leading companies, including Abbott Labs, Apple Inc., Johnson & Johnson, Medella Health, Medtronic, Roche, Sanofi and Unilife Corp
Published - Nov-2014| Analyst - Valerie Kellogg| Code - HLC102B

Report Highlights

The global market for continuous glucose monitoring products totaled $279.4 million in 2013. This market reached $320.9 million in 2014 and is expected to reach $783.9 million in 2019, registering a compound annual growth (CAGR) of 19.6% from 2014-2019.

Report Includes

  • An overview of the global market for continuos glucose monitoring (CGM).
  • Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Examination of the critical issues of the CGM market including technological developments, geographic trends, market dynamics and adoption trends
  • Market breakdowns by application area: hospitals, diagnostics/clinics, home
  • Information broken down by age: children, teens, young, middle, elderly; by race: non-Hispanic whites, Hispanics, Asian Americans, Europeans, Asians, others; and by geography: the U.S., Europe, Asia, and the rest of the world
  • Receive information on leading companies including their product portfolios and recent developments.

Published - Jun-2012| Analyst - Varsha Bhat| Code - HLC102A

Report Highlights

The global market for continuous glucose monitoring (CGM) devices was worth $165.8 million in 2010 and $183.7 million in 2011. This market is projected to reach $356.5 million by 2016, with a five-year compound annual growth rate (CAGR) of 14.2% from 2011 through 2016.

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS